Chemoinformaics analysis of Delta-13(18)-Glaucarubin
| Molecular Weight | 496.553 | nRot | 3 |
| Heavy Atom Molecular Weight | 460.265 | nRig | 25 |
| Exact Molecular Weight | 496.231 | nRing | 5 |
| Solubility: LogS | -3.384 | nHRing | 2 |
| Solubility: LogP | 1.123 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 73.7746 |
| nHD | 5 | BPOL | 43.0595 |
| QED | 0.258 |
| Synth | 6.785 |
| Natural Product Likeliness | 3.802 |
| NR-PPAR-gamma | 0.531 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.88 |
| Pgp-sub | 0.998 |
| HIA | 0.884 |
| CACO-2 | -5.4 |
| MDCK | 0.000114657 |
| BBB | 0.595 |
| PPB | 0.479092 |
| VDSS | 0.956 |
| FU | 0.39372 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.632 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.619 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.071 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.226 |
| CL | 2.178 |
| T12 | 0.042 |
| hERG | 0.005 |
| Ames | 0.02 |
| ROA | 0.165 |
| SkinSen | 0.008 |
| Carcinogencity | 0.012 |
| EI | 0.005 |
| Respiratory | 0.114 |
| NR-Aromatase | 0.279 |
| Antiviral | Yes |
| Prediction | 0.776475 |